ROR2, VANGL2, and DVLs were demonstrated to be involved in the WNT pathway [54, 55], serving as pivotal regulators of proliferation, metastasis, and development of colon cancer, thyroid cancer, and melanoma [56–59]. This evidence concerns the gene ROR2 and thyroid gland carcinoma.